Bioinformatic analysis of patient-derived ASPS gene expressions and ASPL-TFE3 fusion transcript levels identify potential therapeutic targets.
Gene expression data, collected from ASPS tumors of seven different patients and from one immortalized ASPS cell line (ASPS-1), was analyzed jointly with patient ASPL-TFE3 (t(X;17)(p11;q25)) fusion transcript data to identify disease-specific pathways and their component genes. Data analysis of the...
Main Authors: | David G Covell, Anders Wallqvist, Susan Kenney, David T Vistica |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3511488?pdf=render |
Similar Items
-
Kidney carcinoma associated with Xp11.2 translocation / TFE3 (ASPL-TFE3) gene fusion
by: Paulo G. O. Salles, et al.
Published: (2005-06-01) -
ASPL-TFE3 Oncoprotein Regulates Cell Cycle Progression and Induces Cellular Senescence by Up-Regulating p21
by: Naoko Ishiguro, et al.
Published: (2016-10-01) -
Gene expression profiling of alveolar soft-part sarcoma (ASPS)
by: Raffeld Mark, et al.
Published: (2009-01-01) -
Study of the transcription factor TFE3 and its fusion partners in renal cell carcinoma
by: Skalsky, Yitzchak
Published: (2000) -
PRCC-TFE3 dual-fusion FISH assay: A new method for identifying PRCC-TFE3 renal cell carcinoma in paraffin-embedded tissue.
by: Lei Xiong, et al.
Published: (2017-01-01)